Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients

NCT00559026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Melan-A
OTHER: Melan-A plus Dacarbazine

Sponsor

Istituto Superiore di Sanità

Collaborators

[object Object]
[object Object]